The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•8 April 2026•

1 min read

Kisses from Italy Pivots to Biotech via Merger with Regen Health Physicians

Key Facts

1Kisses from Italy (KITL) announced a business combination with Regen Health Physicians of New York City.

2The company is transitioning from a restaurant operator and distributor to an aesthetic biologic and regenerative health company.

3Regen Health will be the first of several planned clinics focusing on stem cell, peptide, and biologic-based regeneration.

Create Free Account

Kisses from Italy Inc. (KITL) has announced a definitive business combination agreement with New York-based Regen Health Physicians. This move marks a significant strategic pivot for the company as it transitions from a restaurant operator and distributor into the aesthetic biologic and regenerative medicine sector. Regen Health is set to become the flagship clinic in a planned expansion focusing on stem cell, peptide, and biologic-based regeneration therapies. By exiting the food and beverage industry, the company aims to capitalize on the high-growth potential of the biotechnology and healthcare markets. Analysts view this shift toward higher-margin operations as a bold move to redefine the company's value proposition. Investors are closely monitoring the execution of this merger and its impact on the company's long-term growth trajectory.